{
  "id": "LSB10049",
  "type": "CRS Report Type LSB",
  "typeId": "LSB",
  "number": "LSB10049",
  "active": false,
  "source": "CRSReports.Congress.gov",
  "versions": [
    {
      "source_dir": "crsreports.congress.gov",
      "title": "Responding to the Opioid Epidemic: Legal Developments and FDA\u2019s Role",
      "retrieved": "2020-09-05T09:21:37.735590",
      "id": "LSB10049_4_2018-03-06",
      "formats": [
        {
          "filename": "files/2018-03-06_LSB10049_ea947fabe48b20fea5b6e7b65edadbf1acf2a852.pdf",
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/LSB/LSB10049/4",
          "sha1": "ea947fabe48b20fea5b6e7b65edadbf1acf2a852"
        },
        {
          "format": "HTML",
          "filename": "files/2018-03-06_LSB10049_ea947fabe48b20fea5b6e7b65edadbf1acf2a852.html"
        }
      ],
      "date": "2018-03-06",
      "summary": null,
      "source": "CRSReports.Congress.gov",
      "typeId": "LSB",
      "active": false,
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=LSB10049",
      "type": "CRS Report Type LSB"
    }
  ],
  "topics": []
}